The United States Pharmacopeia (USP) requested NCPDP’s support in responding to a provision relating to biologics included in the Senate Health, Education, Labor & Education (HELP) Committee Medical Innovation Package. The provision would exempt biological medicines from the requirement to adhere to USP public standards for quality. NCPDP agrees that, if enacted, this provision would have potentially grave consequences for public health and safety. NCPDP is an Observer Organizational Member of USP and shares a common vision for patient safety.

For problems with the site please contact us at